Paperpal Prime Logo

Journal of Pharmacology and Experimental Therapeutics : Impact Factor & More

eISSN: 1521-0103pISSN: 0022-3565

Key Metrics

CiteScore
7.1
Impact Factor
< 5
SNIP
1.04
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Pharmacology and Experimental Therapeutics

Journal of Pharmacology and Experimental Therapeutics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1909
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Pharmacology and Experimental Therapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Pharmacology and Experimental Therapeutics

Corrigendum to "Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury".
  • 28 Jan 2027
  • The Journal of pharmacology and experimental therapeutics
Reframing SGLT2 inhibition: Anti-inflammatory mechanisms and drug target insights emerging from EMPA-TROPISM.
  • 11 Jun 2026
  • The Journal of pharmacology and experimental therapeutics
Integrating CYP2D6 and MATE1 activities in drug-drug interaction assessment: Insights from newly developed antidepressant drug ammoxetine.
  • 4 Jun 2026
  • The Journal of pharmacology and experimental therapeutics
Nanomedicine to enhance melanoma radiotherapy: Mechanisms and translational prospects.
  • 1 Jun 2026
  • The Journal of pharmacology and experimental therapeutics
An antidote in arms: A monoclonal antibody intervention to reverse fentanyl-induced respiratory apnea.
  • 1 Jun 2026
  • The Journal of pharmacology and experimental therapeutics
Enhanced antinociception of mixed efficacy opioid peptidomimetics through P-glycoprotein modulation.
  • 1 Jun 2026
  • The Journal of pharmacology and experimental therapeutics
Corrigendum to "Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury".
  • 28 Jan 2027
  • The Journal of pharmacology and experimental therapeutics
Reframing SGLT2 inhibition: Anti-inflammatory mechanisms and drug target insights emerging from EMPA-TROPISM.
  • 11 Jun 2026
  • The Journal of pharmacology and experimental therapeutics
Integrating CYP2D6 and MATE1 activities in drug-drug interaction assessment: Insights from newly developed antidepressant drug ammoxetine.
  • 4 Jun 2026
  • The Journal of pharmacology and experimental therapeutics
Nanomedicine to enhance melanoma radiotherapy: Mechanisms and translational prospects.
  • 1 Jun 2026
  • The Journal of pharmacology and experimental therapeutics
An antidote in arms: A monoclonal antibody intervention to reverse fentanyl-induced respiratory apnea.
  • 1 Jun 2026
  • The Journal of pharmacology and experimental therapeutics
Enhanced antinociception of mixed efficacy opioid peptidomimetics through P-glycoprotein modulation.
  • 1 Jun 2026
  • The Journal of pharmacology and experimental therapeutics

FAQs on Journal of Pharmacology and Experimental Therapeutics